Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found researchers at Weill Cornell Medicine, the College of Veterinary Medicine at Cornell University and the National Institutes of Health's (NIH)...
Antiviral-resistant variants of SARS-CoV-2 can emerge in immunocompromised people retrieved 18 September 2024 from https://medicalxpress.com/news/2024-09-antiviral-resistant-variants-sars-cov.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.19 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
To subvert immune response, SARS-CoV-2 stimulates production of proteins without protective functionTo evade the human host's immune response, SARS-CoV-2, the coronavirus that causes COVID-19 uses the machinery of defense cells to induce the expression of unproductive isoforms of key antiviral genes—variant forms of genes that result from disrupted splicing or transcription processes and do not code for functional (protective) proteins.
Read more »
Synergistic mutations found in omicron variant of SARS-CoV-2Certain changes in the genetic material of pathogens can alter their ability to infect human cells or protect them better from defense by the immune system. Researchers were able to observe this effect particularly impressively in the SARS-CoV-2 virus.
Read more »
Spike mutations that help SARS-CoV-2 infect the brain discoveredScientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system.
Read more »
Mutation in SARS-CoV-2 spike protein enhances brain infectionScientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system.
Read more »
Study finds higher SARS-CoV-2 risk in obese individualsA study finds an increased risk of developing a productive SARS-CoV-2 infection in obese people. Obesity is known to predict worse outcomes and higher mortality for those with COVID-19. Masanori Aikawa and colleagues sought to determine if obesity also affected the likelihood of getting ill in the first place.
Read more »
SARS-CoV-2 evolves differently in the brain, revealing critical insights into viral tropismStudy investigates the evolution of SARS-CoV-2 within the central nervous system (CNS) compared to the lungs in mice, revealing higher viral divergence in the CNS and highlighting the critical role of the furin cleavage site (FCS) in viral tropism and compartmentalization.
Read more »